Delivery Order SPE2DB22D2007-SPE2DB25FJ4KT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,513.30 to AmerisourceBergen Drug Corp for 60 units of TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder used for chronic obstructive pulmonary disease management. The contract is a firm fixed-price delivery order with an ultimate completion date of December 18, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $14,019.75 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication used in the treatment of chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order was issued on August 21, 2025, with an ultimate completion date of August 22, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,850.74 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used in the treatment of chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order was issued on July 31, 2025, with an ultimate completion date of August 1, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,888.15 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The contract, awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $10,252.23 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The contract, which was competitively awarded without set-aside provisions, carries a firm fixed price structure and was finalized on November 4, 2025, with an ultimate completion date of November 5, 2025. The pharmaceutical will be delivered to Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $10,859.04 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder used to treat chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order was issued on September 11, 2025, with an ultimate completion date of September 12, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $12,684.03 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. Issued on September 23, 2025, with completion targeted for September 24, 2025, this firm fixed-price delivery order represents a routine pharmaceutical procurement under a competitive, non-set-aside arrangement. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $8,409.03 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The competitively awarded, firm fixed-price delivery order was placed on August 8, 2025, with an ultimate completion date of August 11, 2025. Performance will be executed from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,417.46 for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation powder medication used in the treatment of chronic obstructive pulmonary disease. Issued on August 5, 2025, with completion targeted for August 6, 2025, this firm fixed-price delivery order represents a routine pharmaceutical procurement under a competitive, non-set-aside award. The contract will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $10,943.18 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. This non-competitive, firm fixed-price delivery order was awarded on December 22, 2025, with an ultimate completion date of December 23, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract represents a child order...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4KTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,185.10 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. This firm fixed price, competitively awarded delivery order was issued on August 27, 2025, with an ultimate completion date of August 28, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through its extensive federal contract portfolio. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support contract enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Through this flexible contracting mechanism, AmerisourceBergen supplies critical medical commodities to customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 8/27/25 |